Showing 1471-1480 of 2314 results for "".
- GLP-1 Receptor Agonists Not Linked With Diabetic Retinopathyhttps://modernod.com/news/glp-1-receptor-agonists-not-linked-with-diabetic-retinopathy/2476245/Glucagon-like peptide 1 receptor agonists (GLP-1RAs) do not appear to increase patients’ risk for diabetic retinopathy, according to an analysis of the FDA Adverse Event Reporting System database, as reported by Reuters Health. <
- USC Roski Eye Institute Scientists Present Latest Research at the ARVO Annual Meetinghttps://modernod.com/news/usc-roski-eye-institute-scientists-present-latest-research-at-the-arvo-annual-meeting/2480198/What do nanophotoswitches, lipid nanoparticles, and mapping the brain have in common? They are among the future-forward areas of vision research being investigated by USC Roski Eye Institute
- After Shortage, Harrow Announces Relaunch of Triesencehttps://modernod.com/news/after-shortage-harrow-announces-relaunch-of-triesence/2482468/Harrow has officially relaunched Triesence (triamcinolone acetonide injectable suspension) 40 mg/mL, a preservative-free synthetic corticosteroid. Triesence is approved by the FDA for use in visualizing tissues during vitrectomy and treating ocular inflammatory conditions that do n
- American Vision Partners Notifies Patients of Cybersecurity Incidenthttps://modernod.com/news/american-vision-partners-notifies-patients-of-cybersecurity-incident/2482103/Medical Management Resource Group (MMRG), doing business as American Vision Partners, provided notice of a cybersecurity incident affecting information the company maintains in connection with performing services. American Vision Partners provides administrative services to ophthalmolog
- Rayner Launches ‘Peer2Peer: The Podcast’ for Clinical Educationhttps://modernod.com/news/rayner-launches-peer2peer-the-podcast-for-clinical-education/2481342/Rayner announced the launch of the latest addition to their Peer2Peer clinical education platform, "Peer2Peer: The Podcast." Topics included in the podcase include the do's and don’ts of implanting toric IOLs; marketing your clinic online; popular
- AXIM Biotech Develops Rapid Quantitative Tear Test for MMP-9, An Inflammatory Biomarker of Dry Eye Diseasehttps://modernod.com/news/axim-biotech-develops-rapid-quantitative-tear-test-for-mmp-9-an-inflammatory-biomarker-of-dry-eye-disease/2480753/AXIM Biotechnologies announced that it has successfully developed a rapid quantitative tear test for MMP-9, an inflammatory biomarker for dry eye disease. "Dry eye disease, though widespread, is under-diagnosed, in part because symptoms do not always
- Modular Super-Enhancer Controls Retinal Developmenthttps://modernod.com/news/modular-super-enhancer-controls-retinal-development/2480571/Scientists at St. Jude Children’s Research Hospital identified distinct functions for regions of a super-enhancer that controls gene expression during retina formation, calling it a ‘modular’ super-enhancer. Enhancers are regions of DNA that do not
- Study Shows Contact Lenses Advantages with Mask Wearhttps://modernod.com/news/study-shows-contact-lenses-advantages-with-mask-wear/2480420/A new study establishes that contact lens wear offers an option for a better vision correction experience than spectacles when paired with face masks, and doing so likely improves adherence to mask use. Conducted by Eurolens Research at the University of Manchester, it is the first work to compar
- AAO: Looks Like the Home Office is Here to Stay. Here’s How to Protect Your Eyeshttps://modernod.com/news/aao-looks-like-the-home-office-is-here-to-stay-heres-how-to-protect-your-eyes/2478962/As home and office space merged during the pandemic, many people said they spent more time in front of screens and suffered because of it. They complained of eye strain, headaches, and dry eye, and worried that they might be doing permanent damage to their vision. Now comes a
- JPM: How did Pfizer Up its COVID-19 Vaccine Capacity? ‘Out of the Box Manufacturing,’ CEO Sayshttps://modernod.com/news/jpm-how-did-pfizer-up-its-covid-19-vaccine-capacity-out-of-the-box-manufacturing-ceo-says/2478757/Earlier this week, Pfizer partner BioNTech upped the pair’s 2021 COVID-19 output projection to 2 billion doses for 2021, up from a previous estimate of 1.3 billion. But how will the companies get there? By doing things “very differently and very out of the box in manufacturing,” CEO Albert Bourla